Previous studies have shown that the neurotoxin dendroaspin and the disintegrin kistrin, which show little overall sequence homology but similar residues around RGD (PRGDMP), preferentially inhibited platelet adhesion to fibrinogen. In contrast, the elegantin which has different amino acids around RGD (ARGDNP) preferentially inhibited platelet adhesion to fibronectin. To investigate further the role of amino acids around RGD in disintegrins, we have constructed the genes of a wild-type and of two mutant dendroaspins with substitutions around the RGD, namely [Asn]- and [Ala,Asn]dendroaspins. Proteins were expressed in Escherichia coli as glutathione S-transferase fusion recombinants and purified to homogeneity by affinity chromatography and reversed phase high performance liquid chromatography. Platelet aggregation studies revealed that wild-type dendroaspin showed an IC value similar to that of native dendroaspin, with [Ala,Asn]dendroaspin showing an IC value similar to that of elegantin. Interestingly, in platelet adhesion assays, the mutants showed a progressive shift in inhibitory preference, in particular, [Ala,Asn]dendroaspin showed nearly identical behavior as elegantin when fibronectin was the immobilized ligand (IC = 0.33 µM and 0.6 µM, respectively, compared with 20 µM for native dendroaspin). Native and recombinant wild-type dendroaspin bound to a single class of binding site exhibiting a K = 67 nM; [Asn]- and [Ala,Asn]dendroaspins, however, both produced biphasic isotherms with Kvalues = 87 nM and 361 nM for [Asn]dendroaspin and 33 nM and 371 nM for [Ala,Asn]dendroaspin, which are close to those of elegantin (K values = 18 nM and 179 nM). These studies prove that the amino acids flanking RGD provide an extended locus that regulate the affinity and selectivity of RGD protein dendroaspin.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. Sumathipala, C. Xu, J. Seago, A. P. Mould, M. J. Humphries, S. E. Craig, Y. Patel, E. S. Wijelath, M. Sobel, and S. Rahman The "Linker" Region (Amino Acids 38-47) of the Disintegrin Elegantin Is a Novel Inhibitory Domain of Integrin {alpha}5beta1-Dependent Cell Adhesion on Fibronectin: EVIDENCE FOR THE NEGATIVE REGULATION OF FIBRONECTIN SYNERGY SITE BIOLOGICAL ACTIVITY J. Biol. Chem., December 8, 2006; 281(49): 37686 - 37696. [Abstract] [Full Text] [PDF]

				G. Wiedle, C. Johnson-Leger, and B. A. Imhof A Chimeric Cell Adhesion Molecule Mediates Homing of Lymphocytes to Vascularized Tumors Cancer Res., October 1, 1999; 59(20): 5255 - 5263. [Abstract] [Full Text] [PDF]

				R. Baluna, J. Rizo, B. E. Gordon, V. Ghetie, and E. S. Vitetta Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome PNAS, March 30, 1999; 96(7): 3957 - 3962. [Abstract] [Full Text] [PDF]

				X.-P. Zhang, T. Kamata, K. Yokoyama, W. Puzon-McLaughlin, and Y. Takada Specific Interaction of the Recombinant Disintegrin-like Domain of MDC-15 (Metargidin, ADAM-15) with Integrin alpha vbeta 3 J. Biol. Chem., March 27, 1998; 273(13): 7345 - 7350. [Abstract] [Full Text] [PDF]

				V. H. Tselepis, L. J. Green, and M. J. Humphries An RGD to LDV Motif Conversion within the Disintegrin Kistrin Generates an Integrin Antagonist That Retains Potency but Exhibits Altered Receptor Specificity. EVIDENCE FOR A FUNCTIONAL EQUIVALENCE OF ACIDIC INTEGRIN-BINDING MOTIFS J. Biol. Chem., August 22, 1997; 272(34): 21341 - 21348. [Abstract] [Full Text] [PDF]

				C. Marcinkiewicz, S. Vijay-Kumar, M. A. McLane, and S. Niewiarowski Significance of RGD Loop and C-Terminal Domain of Echistatin for Recognition of alpha IIbbeta 3 and alpha vbeta 3 Integrins and Expression of Ligand-Induced Binding Site Blood, August 15, 1997; 90(4): 1565 - 1575. [Abstract] [Full Text] [PDF]

				J. Takagi, T. Kamata, J. Meredith, W. Puzon-McLaughlin, and Y. Takada Changing Ligand Specificities of alpha vbeta 1 and alpha vbeta 3 Integrins by Swapping a Short Diverse Sequence of the beta  Subunit J. Biol. Chem., August 8, 1997; 272(32): 19794 - 19800. [Abstract] [Full Text] [PDF]

				P. Marchot, C. N. Prowse, J. Kanter, S. Camp, E. J. Ackermann, P. E. Bougis, and P. Taylor Expression and Activity of Mutants of Fasciculin, a Peptidic Acetylcholinesterase Inhibitor from Mamba Venom J. Biol. Chem., February 7, 1997; 272(6): 3502 - 3510. [Abstract] [Full Text] [PDF]